ArticleInternational journal of molecular sciences2022

Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through Suppressing PI3K and c-KIT Signaling in Acute Myeloid Leukemia.

Chan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.